# A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer

> **NCT03327064** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Non-melanoma Skin Cancer

## Interventions

- **DRUG:** UAB30
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03327064
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-10-01
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** COVID-19 pandemic, unable to enroll participants
- **Last updated:** 2024-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03327064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03327064, "A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03327064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*